The University of Chicago Header Logo

Connection

Everett E. Vokes to Pyrrolidinones

Back to Details
This is a "connection" page, showing publications Everett E. Vokes has written about Pyrrolidinones.
Everett E. Vokes
Connection Strength
0.186
Pyrrolidinones
  1. A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Cancer. 2020 05 15; 126(10):2146-2152.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.